0001209191-16-096429.txt : 20160208
0001209191-16-096429.hdr.sgml : 20160208
20160208171129
ACCESSION NUMBER: 0001209191-16-096429
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160204
FILED AS OF DATE: 20160208
DATE AS OF CHANGE: 20160208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Janssen Robert
CENTRAL INDEX KEY: 0001580849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 161396385
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES
STREET 2: 2929 SEVENTH STREET, SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-04
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001580849
Janssen Robert
C/O DYNAVAX TECHNOLOGIES
2929 SEVENTH STREET, SUITE 100
BERKELEY
CA
94710
0
1
0
0
Vice President
Restricted Stock Unit
2016-02-04
4
A
0
20000
A
2026-02-03
Common Stock
20000
20000
D
Option (Right to Buy)
21.99
2016-02-04
4
A
0
80000
A
2023-02-03
Common Stock
80000
80000
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
These restricted stock units shall vest upon achievement of certain performance conditions.
Not applicable.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date,
and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter, providing further that the options
are subject to approval by our stockholders of an increase in the number of shares available under the 2011 Equity Incentive Plan.
Robert Janssen, by /s/ Michael Ostrach, Attorney-in Fact
2016-02-08